We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Novel Surface Treatment Stops Microbes from Adhering to Medical Devices

By HospiMedica International staff writers
Posted on 23 May 2022
Print article
Image: Novel surface treatment could prevent deadly hospital infections without antibiotics (Photo courtesy of Penn State)
Image: Novel surface treatment could prevent deadly hospital infections without antibiotics (Photo courtesy of Penn State)

Hospitals and medical clinics can be the source of nasty infections, resulting in death from infection-related complications and billions in direct medical costs. The biggest culprits, experts say - accounting for two-thirds of these infections - are medical devices like catheters, stents, heart valves and pacemakers, whose surfaces often become covered with harmful bacterial films. Now, a novel surface treatment developed by scientists could help improve the safety of these devices and ease the economic burden on health care systems.

The new approach developed by a team of scientists at UCLA (Los Angeles, CA, USA) and tested in both laboratory and clinical settings, involves depositing a thin layer of what is known as zwitterionic material on the surface of a device and permanently binding that layer to the underlying substrate using ultraviolet light irradiation. The resulting barrier prevents bacteria and other potentially harmful organic materials from adhering to the surface and causing infection. In the laboratory, researchers applied the surface treatment to several commonly used medical device materials, then tested the modified materials’ resistance to various types of bacteria, fungi and proteins. They found that the treatment reduced biofilm growth by more than 80% - and in some cases up 93%, depending on the microbial strain.

The clinical research by the UCLA scientists involved 16 long-term urinary catheter users who switched to silicone catheters with the new zwitterionic surface treatment. Catheter-related urinary tract problems are illustrative of the issues plaguing other medical devices, which, once inserted or implanted, can become breeding grounds for bacteria and harmful biofilm growth. The pathogenic cells pumped out by these highly resilient biofilms then cause recurring infections in the body. In response, medical staff routinely adminster strong antibiotics to patients using these devices, a short-term fix that poses a longer-term risk of creating life-threatening, antibiotic-resistant “superbug” infections. The more widely and frequently antibiotics are prescribed, the more likely bacteria are to develop resistance to them.

Ten of the patients described their urinary tract condition using the surface-treated catheter as “much better” or “very much better,” and 13 chose to continue using the new catheter over conventional latex and silicone options after the study period ended. The surface treatment’s zwitterion polymers are known to be extremely biocompatible, and they absorb water very tightly, forming a thin hydration barrier that prevents bacteria, fungi and other organic materials from adhering to surfaces. The technology is highly effective, non-toxic and relatively low in cost compared with other current surface treatments for medical devices, like antibiotic- or silver-infused coatings. Beyond its use in medical devices, the surface treatment technique could have non-medical applications, potentially extending the lifetimes of water-treatment devices and improving lithium-ion battery performance.

“The beauty of this technology is that it can prevent or minimize the growth of biofilm without the use of antibiotics. It protects patients using medical devices - and therefore protects all of us - against microbial resistance and the proliferation of superbugs,” said Richard Kaner, UCLA’s Dr. Myung Ki Hong Professor of Materials Innovation and senior author of the research.

Related Links:
UCLA 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Heart-Lung Machine
HL 40

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.